Editor’s Note: This article originally appeared on LogicStream’s website.
As summer weather and family vacations beckon more people outdoors, the ongoing shortage of EpiPens poses a serious risk for people allergic to insect bites. EpiPen, the leading brand of epinephrine auto-injectors, provides emergency treatment for life-threatening allergic reactions to stings, foods, drugs and other substances.
The lack of EpiPens is yet another patient safety risk brought on by ongoing drug shortages. The medication saves lives by rapidly improving breathing, stimulating the heart, raising blood pressure and reducing swelling of the face, lips and throat. The EpiPen shortage, which has lasted more than a year, produces increasing anxiety among people with severe allergies and those who care for them. Click here to continue>>
News From Our Partners
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
